Weight Gain Timing Affects Prostate Cancer Risk: Patterns Differ by Ethnic Group
Preventing Prostate Cancer - Obesity
By Tuesday, September 01 2009 13:00
Body mass in younger and older adulthood, and weight gain between these periods of life, may influence a man’s risk for prostate cancer. This risk varies among different ethnic populations, according to results of a study in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Hormone Therapy Riskier for Prostate Cancer Patients With Heart Conditions
By Wednesday, August 26 2009 06:13
Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to a study in the August 26 issue of JAMA.
New Look at Side Effects of Androgen Deprivation Therapy for Prostate Cancer
By Thursday, April 30 2009 03:49
Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis. A new review of the data suggests that the absolute increases in these risks are fairly low, but proper care is essential to minimize them.
AUA New Guidelines on Prostate Cancer Screening
Diagnosis + Stage - Screening for prostate cancer
Tuesday, April 28 2009 01:21
The American Urological Association (AUA) today issued new clinical guidance about prostate cancer screening. The guidelines were announced at the association's annual meeting by Peter Carroll, chair of the panel that developed the Statement. The AUA states that its guidelines directly contrast with recent recommendations issued by other major groups.
AUA advises that the prostate-specific antigen (PSA) test should be offered to well-informed men aged 40 years or older who have a life expectancy of at least 10 years.
Sunday, April 26 2009 20:46
For Men, keeping cholesterol low protects against prostate cancer and erectile dysfunction
Statins, drugs widely prescribed to lower cholesterol, may have protective effects on prostate health and on male erectile function. A large Mayo Clinic study co-sponsored by Merck and Kaiser Permanente looked at possible effects of statins on three different aspects of urological health – prostate cancer, erectile dysfunction and prostate enlargement.
More Articles...
Page 3 of 8
